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Summary
Skeletal muscle mitochondrial oxidative capacity declines with
age and negatively affects walking performance, but the mech-
anism for this association is not fully clear. We tested the
hypothesis that impaired oxidative capacity affects muscle per-
formance and, through this mechanism, has a negative effect on
walking speed. Muscle mitochondrial oxidative capacity was
measured by in vivo phosphorus magnetic resonance spec-
troscopy as the postexercise phosphocreatine resynthesis rate,
kPCr, in 326 participants (154 men), aged 24–97 years (mean 71), in
the Baltimore Longitudinal Study of Aging. Muscle strength and
quality were determined by knee extension isokinetic strength,
and the ratio of knee extension strength to thigh muscle cross-
sectional area derived from computed topography, respectively.
Four walking tasks were evaluated: a usual pace over 6 m and for
150 s, and a rapid pace over 6 m and 400 m. In multivariate linear
regression analyses, kPCr was associated with muscle strength
(b = 0.140, P = 0.007) and muscle quality (b = 0.127, P = 0.022),
independent of age, sex, height, and weight; muscle strength
was also a significant independent correlate of walking speed
(P < 0.02 for all tasks) and in a formal mediation analysis
significantly attenuated the association between kPCr and three
of four walking tasks (18–29% reduction in b for kPCr). This is the
first demonstration in human adults that mitochondrial function
affects muscle strength and that inefficiency in muscle bioener-
getics partially accounts for differences in mobility through this
mechanism.
Key words: 31P MRS; bioenergetics; in vivo; muscle strength;
skeletal muscle; walking speed.
Introduction
Walking independently is essential for performing daily living activities
and maintaining independence throughout the human lifespan (Halter
et al., 2009). Preferred walking speed often slows with increasing age in
older adults (Cunningham et al., 1982), and this metric of lower
extremity performance is a strong predictor of disability, functional
dependence, and mortality in the adult and older population (Guralnik
et al., 1995; Studenski et al., 2011; Schrack et al., 2012). As walking is a
complex task requiring energy, balance, movement control, and
coordination of the musculoskeletal, nervous, respiratory, and cardio-
vascular systems, it is difficult to evaluate the extent to which loss of
mobility with aging can be attributed to any single factor (Ferrucci et al.,
2016).
In a previous study conducted on participants drawn from the
Baltimore Longitudinal Study of Aging (BLSA), we demonstrated that
skeletal muscle mitochondrial oxidative capacity (as measured by in vivo
phosphorus magnetic resonance spectroscopy, 31P MRS, in the quadri-
ceps) is a strong independent predictor of walking speed, and this
association between oxidative capacity and walking speeds is especially
strong for more challenging gait tasks (Choi et al., 2016). These findings
suggested that diminished bioenergetic reserve (Schrack et al., 2013)
and/or impaired bioenergetic synthetic capacity is in part responsible for
slower walking speeds in older persons. This hypothesis is consistent with
the progressive decline in muscle mass and strength (with the decline in
strength outpacing that of muscle mass) (Goodpaster et al., 2006;
Newman et al., 2006) often observed in older persons and attributed in
part to higher prevalence of chronic diseases (McDermott et al., 2004)
and lower physical activity in older compared with younger persons
(Cesari et al., 2009).
Studies conducted in animal models and in humans have shown that
skeletal muscle mitochondrial oxidative capacity declines with age
(Conley et al., 2000; Short et al., 2005; Fleischman et al., 2010;
Peterson et al., 2012), likely due to a decline in both total mitochondrial
mass and decreased intrinsic mitochondrial functional capacity (Conley
et al., 2000). This steady decline of mitochondrial function with aging is
believed to contribute to the progressive deterioration of muscle
strength and quality (Metter et al., 1999), as diminished energy
production may constrain muscle performance, and dysfunctional
mitochondria create oxidative stress that can damage proteins and
mitochondrial DNA (Peterson et al., 2012). Thus, it is reasonable to
hypothesize that the association between decreased skeletal muscle
bioenergetics synthetic capacity and slower walking speed shown in our
previous study is mediated by the deleterious effect of impaired oxidative
capacity on muscle performance; that is, that lower mitochondrial
function relates to lower muscle strength, which in turn relates to slower
walking speed. We hypothesize that this pathway explains, in part, the
link between muscle mitochondrial function and walking speed.
Muscle mitochondrial function can be studied by in vivo 31P MRS, a
noninvasive technique used to assess the rate of maximum in vivo
oxidative capacity of skeletal muscle by quantitatively measuring
phosphorus-containing metabolites—phosphocreatine (PCr), inorganic
phosphate (Pi), and adenosine triphosphate (ATP) (Chance et al., 1981;
Edwards et al., 2012). This method is reproducible (McCully et al.,
2009), can be focused to a specific, single muscle (McCully et al., 1993),
is not affected by postural or balance impairments, and has been
validated against in vitro techniques (McCully et al., 1993; Conley et al.,
2000). Muscular oxidative capacity is indexed by the postexercise PCr
resynthesis rate constant, or kPCr, which is determined by monitoring the
mono-exponential recovery of PCr (Meyer, 1988) in the rest period
following an exercise-induced depletion. This rate constant, kPCr, has
been established as a measure of mitochondrial ATP production
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(McCully et al., 1993, 2009; Conley et al., 2000; Edwards et al., 2012;
Coen et al., 2013).
This cross-sectional study uses data from the BLSA to test the
hypothesis that this relationship is mediated, at least in part, by the age-
related decline in muscle strength. Specifically, we examined whether
kPCr is an independent predictor of muscle strength, and of walking
speed in four different walking tasks (Coen et al., 2013; Choi et al.,
2016). Then, we performed a formal mediation analysis to evaluate
whether the association between mitochondrial function and walking
speed is mediated by impaired muscle strength.
Results
The cross-sectional study sample included 326 participants, 47% men,
with a mean age of 71.4 years (range 24–97 years). Figure 1 shows,
as expected, that there is an overall decline of muscle strength with
age. To compare individuals with differences in maximum quadriceps
muscle strength independent of age, we stratified the study popu-
lation by age decades, dividing participants within each decade
according to strength tertiles before cumulating them across age
decades. The three groups so identified are shown as indicated in
different colors (Fig. 1); their descriptive summary characteristics are
compared in Table 1. By design, age did not differ across the three
strength groups (Table 1). Maximum quadriceps muscle strength was
lower in women than in men (i.e., women made up 86% of the low
muscle strength tertile), and height, weight, and thigh muscle cross-
sectional area were higher across muscle strength tertiles (P < 0.001
for all; Table 1). Further, the median kPCr was higher with increasing
muscle strength (P = 0.036), and % PCr depletion was also different
across the groups (Table 1), with greater depletion corresponding to
greater strength. Four walking tasks were tested: UGS-6 m (usual gait
speed, for a distance of 6 m), UGS-150 m (usual gait speed, 150 m),
RGS-6m (rapid gait speed, 6 m), and RGS-400m (rapid gait speed,
400 m). The average walking speeds were faster with increasing
muscle strength (P < 0.01 for all).
After adjustment for age, sex, height, weight, and % PCr depletion,
kPCr was significantly and positively associated with maximum quadri-
ceps muscle strength considered as a continuous variable (P = 0.007)
and muscle quality (calculated as the ratio of left quadriceps peak torque
at 30° per s to left thigh muscle cross-sectional area, Nm cm2,
P = 0.022), but not thigh muscle cross-sectional area (P = 0.141,
Table 2). These analyses were based on the 326 participants who had
complete information for spectroscopy and muscle characteristics. As
subsequent analyses were based on the subgroup of individuals who also
had data on walking speed, we repeated the analyses reported in
Table 2, limited to the 316 participants with complete data, and
obtained results that were substantially similar to the original (Table S2,
Supporting information).
For all four walking tasks (UGS-6 m, UGS-150s, RGS-6m, and RGS-
400m), kPCr was a significant independent predictor of walking speed
(P < 0.05 for all) when adjusting for age, sex, height, weight, and % PCr
depletion (Table 3). In agreement with previous findings (Choi et al.,
2016), we found that this association was strongest for the most
challenging task, RGS-400m (b = 0.208, P < 0.001). While Choi et al.
did not find a significant association between kPCr and UGS-6 m (the
least challenging gait task), in this larger sample, this association became
statistically significant, and remained significant after adjusting for
confounders. In separate linear regression models adjusted for age, sex,
height, and weight, maximum quadriceps muscle strength alone was
found to be a significant, independent correlate of walking speed in all
four walking tasks, with the association again being the strongest for the
most challenging task, RGS-400m (b = 0.350, P < 0.001). Of note,
when we introduced into the statistical models an index variable
distinguishing the data analyzed in the previous paper (period = 0), and
those added to the analytical sample later on (period = 1), and we tested
for a kPCr*period interaction, this term was never statistically significant,
suggesting that our data did not substantially change after expanding
the sample size (P > 0.10, see Statistical analyses section). In all analyses,
relationships between kPCr and muscle strength were stronger than
analogous relationships between kPCr and muscle quality. Therefore,
subsequent mediation analyses and walking speed models only included
muscle strength as a predictor, and not muscle quality.
Further analyses were aimed at testing the hypothesis that the
relationship of mitochondrial function with muscle strength was
mediated by a pro-inflammatory state or a status of impaired glucose
metabolism. In preliminary analyses, we found nonsignificant age-, sex-,
height-, weight- and PCr depletion-adjusted partial correlations of kPCr
with fasting glucose (r = 0.029, P = 0.619), fasting insulin
(r = 0.084, P = 0.151), 2-h glucose after an oral glucose tolerance
test (r = 0.048, P = 0.407), and IL-6 (r = 0.085, P = 0.152). In
addition, multivariate regression models predicting maximum quadriceps
muscle strength (adjusting for the same covariates) did not substantially
alter the size and significance of the effect of kPCr on maximum
quadriceps muscle strength (data not shown).
In linear regression models that included both kPCr and muscle
strength, for all four walking tasks, the relationship between kPCr and
walking speed was attenuated by the inclusion of muscle strength (with
a reduction in the magnitude of the b coefficient ranging from 16 to
29%) and only remained significant for RGS-400m (b = 0.170,
P < 0.001). In contrast, muscle strength remained statistically significant
for all four walking speed outcomes, with estimated coefficients
decreasing only by 2–6% when accounting for kPCr. This mediation
effect was confirmed by significant (P < 0.040) Sobel test statistics for
three of the four walking speed tasks: UGS-150 m indirect effect of
0.894 (95% CI = 0.18, 1.872), RGS-6m indirect effect 1.993 (95% CI =
0.447–4.040), RGS-400m indirect effect 1.816 (95% CI = 0.461–
3.442), with muscle strength as a mediator explaining 18–29% of the
influence of kPCr on these three walking tasks. The Sobel test statistic for
the least challenging task, UGS-6 m, was not significant (P = 0.075,
Fig. 1 Age versus muscle strength stratified by age-specific muscle strength
tertiles, for 326 participants in the Baltimore Longitudinal Study of Aging.
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indirect effect = 0.835, CI 0.072–1.950), although muscle strength was
calculated to account for 17% of the effect of kPCr on walking speed
even in this case.
Discussion
This study shows an association between an in vivo 31P MRS-measured
index of skeletal muscle mitochondrial oxidative capacity and four
measures of walking speed in the largest sample to date (n = 316).
Adjusting for age, sex, height, weight, and % PCr depletion, higher
oxidative capacity was positively associated with faster walking speeds
for all four walking tasks, reinforcing the proposition that a progressive
deterioration of muscle bioenergetics with aging exerts influence on gait
speeds (Coen et al., 2013) and that muscle mitochondrial oxidative
capacity may be especially rate-limiting for tasks requiring more exertion
(Choi et al., 2016).
To further explore the mechanism by which mitochondrial oxidative
capacity affects walking speeds, in the present study, we tested the
hypothesis that the relationship between kPCr and walking speed
outcomes is mediated by, at least in part, muscle strength (Fig. 2). We
showed that independent of potential confounders, kPCr is significantly
correlated with muscle strength and quality. Several mechanisms may
account for this association. First, decreasing mitochondrial oxidative
capacity with age results from the combination of decreasing mito-
chondrial volume and increasing mitochondrial dysfunction (Peterson
et al., 2012). Mitochondrial dysfunction creates oxidative stress by
generating reactive oxygen species (ROS) that can damage mitochondrial
DNA (Peterson et al., 2012), impair calcium regulation, and affect
myofilament structure and function (Powers et al., 2011). These would
all act to decrease skeletal muscle force production. An additional
possibility is that diminished ATP synthetic capacity could affect the
efficiency of the skeletal muscle cross-bridge cycle, which is coupled to
the myosin ATPase-controlled hydrolysis of ATP and is responsible for
skeletal muscle force production (Holmes & Geeves, 2000).
In a previous study, Fleischman and collaborators similarly tested the
association between 31P muscle bioenergetics and maximal voluntary
contraction of the knee extensor muscle (Fleischman et al., 2010). They
found that this association was no longer significant when adjusted for
age and covariates. However, the participants evaluated by Fleischman
and collaborators were children (8–17 years) and middle-aged adults
Table 1 Distribution of selected characteristics of the 326 participants from the Baltimore Longitudinal Study of Aging, according to age-adjusted muscle strength tertile
[given as mean (SD)]
Characteristic
Muscle strength tertiles (Nm, 30° per s)
P-value
Low Middle High
n 111 106 109
Age (years) 326 71.63 (12.98) 71.74 (12.59) 70.75 (12.26) 0.820
Sex (female) 326 96 (86%) 57 (54%) 19 (17%) <0.001*‡
Height (cm) 326 161.17 (8.54) 168.22 (7.92) 173.30 (7.97) <0.001*§
Weight (kg) 326 68.20 (15.29) 75.48 (14.10) 82.96 (12.43) <0.001*§
kPCr (per s)† 326 0.019 (0.006) 0.020 (0.007) 0.021 (0.006) 0.036*¶
% PCr depletion 326 34.69 (10.05) 36.66 (11.41) 41.58 (11.60) <0.001*§
Thigh muscle cross-sectional area (cm2) 326 85.77 (23.48) 102.27 (27.46) 125.91 (26.40) <0.001*¶
Usual gait speed, UGS-6m (m s1) 316 1.16 (0.19) 1.22 (0.21) 1.24 (0.21) 0.009*§
Usual gait speed, UGS-150m (m s1) 316 1.20 (0.14) 1.22 (0.16) 1.26 (0.15) 0.009*§
Rapid gait speed, UGS-6m (m s1) 316 1.75 (0.28) 1.85 (0.34) 1.91 (0.37) <0.001*§
Rapid gait speed, UGS-400m (m s1) 316 1.45 (0.20) 1.49 (0.24) 1.58 (0.25) <0.001*§
†Expressed as: median (IQR).
‡Fisher’s exact test P-value.
§Adjusted for age and sex.
¶Jonckheere–Terpstra test P-value.
*Statistically significant
Table 2 Linear regression models for kPCr rates predicting left thigh muscle cross-sectional area, muscle strength, and muscle quality, adjusted for age, sex, height, and
weight, and corrected for % PCr depletion. All coefficients are standardized
N = 326, male = 154
Parameters Muscle area (cm2) Muscle strength (Nm) Muscle quality (Nm cm2)
Adj. R2 0.765 0.531 0.183
b (95% CI) P-value b (95% CI) P-value b (95% CI) P-value
Age 0.367 (0.427, 0.306) <0.001* 0.313 (0.398, 0.228) <0.001* 0.270 (0.139, 0.085) 0.633
Sex 0.543 (0.467, 0.619) <0.001* 0.326 (0.219, 0.433) <0.001* 0.188 (0.330, 0.046) 0.010*
Height (cm) 0.098 (0.190, 0.006) 0.037* 0.212 (0.082, 0.341) 0.002* 0.414 (0.243, 0.585) <0.001*
Weight (kg) 0.430 (0.357, 0.504) <0.001* 0.066 (0.037, 0.170) 0.210 0.374 (0.511, 0.238) <0.001*
kPCr (per s) 0.044 (0.014, 0.102) 0.141 0.114 (0.032, 0.197) 0.007* 0.127 (0.019, 0.236) 0.022*
% PCr dep. 0.005 (0.061, 0.051) 0.857 0.217 (0.138, 0.296) <0.001* 0.323 (0.219, 0.427) <0.001*
*Statistically significant
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(18–55 years) (Fleischman et al., 2010); the relationship between
mitochondrial function and muscle strength may be different in
prepubescent children, and in this population, the degree of age-related
mitochondrial impairment may also be small and unlikely to critically
affect muscle contraction. This is consistent with the decline in aerobic
fitness being relatively modest in young and middle age, likely due to a
relative stability of mitochondrial volume and function (Short et al.,
2005; Peterson et al., 2012).
In contrast, we studied a much older population that included persons
with relatively poor muscle strength and slower walking speeds or
impaired gait capability. In this population, even a single muscle
contraction may be an energetic challenge that is sensitive to even
minor reductions in muscle oxidative capacity. In this sense, our findings
are consistent with those of Bourdel-Marchasson and collaborators, who
show that muscle mitochondrial function is related to global physical
functional status, particularly in hospitalized and frail older subjects
(Bourdel-Marchasson et al., 2007). Our findings are also consistent with
recent reports in the literature that associate cumulative mitochondrial
DNA polymorphisms and circulating mitochondrial DNA copy number
with frailty (Moore et al., 2010). Of interest, the strong association
Table 3 Linear regression models (N = 316 for all) for each walking speed (WS) task, showing the association between muscle strength (MS) and walking speed (Model 1),
and the effect of kPCr on walking speed, without (Model 2) and with (Model 3) accounting for muscle strength. All models are adjusted for age, sex, height, weight, and %
PCr depletion, and all coefficients are standardized
Parameters
Model 1: WS = MS Model 2: WS = kPCr Model 3: WS = kPCr + MS
b (95% CI) P-value b (95% CI) P-value b (95% CI) P-value
Walking Speed = UGS-6 m (m s1)
Age 0.278 (0.396, 0.161) <0.001* 0.305 (0.418, 0.192) <0.001* 0.251 (0.371, 0.130) <0.001*
kPCr (per s) – – 0.122 (0.012, 0.232) 0.030* 0.102 (0.009, 0.213) 0.072
% PCr depletion – – 0.031 (0.075, 0.136) 0.568 0.008 (0.118, 0.101) 0.879
Muscle strength, MS (Nm) 0.180 (0.042, 0.319) 0.011* – – 0.175 (0.031, 0.320) 0.018*
Walking Speed = UGS-150s (m s1)
Age 0.148 (0.270, 0.026) 0.018* 0.198 (0.316, 0.080) 0.001* 0.118 (0.243, 0.006) 0.064
kPCr (per s) – – 0.140 (0.025, 0.255) 0.018* 0.110 (0.004, 0.225) 0.060
% PCr depletion – – 0.045 (0.065, 0.155) 0.424 0.012 (0.126, 0.101) 0.830
Muscle strength, MS (Nm) 0.261 (0.118, 0.405) <0.001* – – 0.257 (0.107, 0.407) 0.001*
Walking Speed = RGS-6m (m s1)
Age 0.379 (0.485, 0.273) <0.001* 0.440 (0.543, 0.337) <0.001* 0.361 (0.470, 0.252) <0.001*
kPCr (per s) – – 0.104 (0.003, 0.205) 0.044* 0.074 (0.025, 0.174) 0.145
% PCr depletion – – 0.088 (0.009, 0.184) 0.075 0.031 (0.068, 0.129) 0.544
Muscle strength, MS (Nm) 0.273 (0.149, 0.398) <0.001* – – 0.256 (0.126, 0.387) <0.001*
Walking Speed = RGS-400m (m s1)
Age 0.452 (0.549, 0.355) <0.001* 0.510 (0.605, 0.415) <0.001* 0.408 (0.506, 0.310) <0.001*
kPCr (per s) – – 0.208 (0.115,0.301) <0.001* 0.170 (0.080, 0.259) <0.001*
% PCr depletion – – 0.094 (0.005, 0.183) 0.039* 0.020 (0.069, 0.109) 0.657
Muscle strength, MS (Nm) 0.350 (0.236, 0.465) <0.001* – – 0.330 (0.212, 0.447) <0.001*
*Statistically significant
Fig. 2 Diagram illustrating: a) the demonstrated effect of kPCr on walking speeds (Choi et al., 2016), b) the effect of kPCr on muscle function, and c) the effect of kPCr on
walking speeds, mediated by muscle function.
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between kPCr and muscle strength, but not muscle mass (Table 2),
suggests that impaired mitochondrial function and efficiency may
account for some of the discrepancy between age-related decline in
muscle strength (dynapenia) and the age-related decline in muscle mass
(sarcopenia) (Manini & Clark, 2012).
When muscle strength was included along with kPCr in the models
predicting walking speed, the relationship between walking speed and
kPCr was attenuated, with a decrease of up to 29% in the kPCr
coefficients, and with loss of statistical significance in all but the most
challenging gait task, RGS-400m (Table 3). This suggests that impaired
overall muscle function accounts for a significant portion of the
association between mitochondrial oxidative capacity and walking
speed. However, in the most strenuous walking task, this mediation
effect was substantially attenuated. This indicates that at this higher level
of physiologic stress, mitochondrial function plays a central role not just
through its effect on muscle strength, but also more directly, through
the role of maintaining an adequate flux of energy during the entire task
(Schrack et al., 2013). Indeed, this finding is consistent with recent
hypotheses that impaired mitochondrial function constitutes part of the
etiology of elevated fatigability in older individuals (Santanasto et al.,
2014), which may contribute to slower gait and loss of mobility
(Vestergaard et al., 2009).
Our findings are based on the largest population ever studied using
in vivo 31P MRS as a measure of mitochondrial oxidative capacity (kPCr), In
addition, we have incorporated multiple state-of-the-art measures of
health and functional status from a well-characterized population.
However, our study also has limitations. We were only able to study
participants who were eligible for and able to complete a thigh CT scan,
the 31P MRS exercise protocol, isokinetic dynamometry, and four walking
speed tasks, all of which may exclude some of the frailest individuals and
thosewith impairedmobility. In addition, the BLSA ismostly comprised of a
relatively healthy and well-educated cohort of volunteers, which may not
be representative of the aging population at large.
The magnitude of the association between mitochondrial energetics
andmobility performance explained bymuscle strength or quality (i.e., the
extent of mediation) is relatively small. This is consistent with the notion
that age-associated mobility decline is multifactorial. Nevertheless, our
findings remain important both for the fundamental understanding of the
physiology of muscle aging and because of the potential development of
exercise and drug therapies to improve mitochondrial function.
In addition, although the development and progression of chronic
disease presumably plays a role in the overall loss of mobility and physical
function with increasing age, we did not include an adjustment for
chronic diseases in our analyses. Diseases such as diabetes also have
specific associations with mitochondrial dysfunction (Sivitz & Yorek,
2010), and the influence of chronic disease on the causal pathway to
mobility loss remains to be elucidated. In contrast, habitual physical
exercise exerts a positive influence on mitochondrial volume (Brierley
et al., 1996). It would be of interest to examine the relationship between
habitual physical activity and measured muscle mitochondrial oxidative
capacity in a future study, to further separate out components and
influences of fitness and exercise on both overall muscle function and
intrinsic mitochondrial capacity. Finally, this study was cross-sectional,
and therefore, we could not fully exclude the possibility of reverse
causality—namely, the possibility that reduced mobility causes muscle
impairment and, in turn, mitochondrial dysfunction. Longitudinal data
on these variables are currently collected in the BLSA.
Overall, our results show that skeletal muscle bioenergetics influence
functional mobility as defined by walking speed and that this influence is
in part mediated by muscle strength and function. We found that this
mediation begins to break down for the most demanding walking tasks,
with bioenergetics playing a more significant direct role at that level of
activity. Thus, interventions aimed at improving muscle mitochondrial
function, as well as maintaining muscle strength and quality, may
reduce, postpone, or prevent mobility loss. Physical exercise is the only
intervention thus far that has been shown to significantly improve
muscle strength in older individuals (Latham et al., 2004). In addition,
there is literature support for the positive role of resistance exercise and
elevated levels of aerobic physical activity on mitochondrial content and
function in the elderly (McCully et al., 1993; Brierley et al., 1996; Jubrias
et al., 2001), presenting a coherent picture with our current results.
Together, these studies provide strong support for exploration of such
interventions as an important prescriptive step in retaining functional
mobility and independence with aging.
Experimental procedures
Participants
The design, study population, and measurement protocols of the BLSA
have been documented previously (Shock et al., 1984). Established in
1958, the BLSA is a continuous enrollment cohort study of community-
dwelling adults conducted by the National Institute on Aging Intramural
Research Program. Participants with no major chronic conditions or
functional impairments are enrolled in the study and follow-up visits occur
at intervals of 1-4 years, becoming more frequent for older participants.
Baseline data on the 31P postexercise recovery rate (kPCr) were collected
from 438 BLSA participants fromApril 2013 to September 2015. Of these,
326 participants (154men), aged 24–97 years (mean 71.4  12.6 years),
had complete datasets including a physical examination, a health history
questionnaire, isometric knee extensor strength testing, and thigh CT
scans; 316participants also hadcompleteddataonwalking speed tasks for
the same visit. As expected, participants who had information on muscle
but not on walking performance (n = 10) had significantly lower muscle
mass and strength (Table S1, Supporting information). Trained and
certified technicians administered all assessments, following standardized
protocols. Height and weight were measured according to standard
protocols, and the average of threemeasureswas used in the analysis. The
National Institute of Environmental Health Sciences Institutional Review
Board approved the study protocol, and all participants gave written
informed consent.
Gait speed metrics
The four gait tasks performed were identical to those outlined previously
(Choi et al., 2016). The usual and rapid short-course gait speed
measurements were performed over a 6-m course; participants were
asked to first walk at their ‘normal walking pace’ (UGS-6 m), then ‘as
fast as possible’ (RGS-6m); the fastest of two trials was used in the
analyses. The long-distance usual and rapid gait speed tasks are
components of the Long Distance Corridor Walk, which uses a 20-m
course in an uncarpeted corridor (Simonsick et al., 2001). The first walk
(UGS-150s) was performed at the participant’s ‘usual, comfortable pace’
for 150 s (2.5 min). The second walk (RGS-400m) follows immediately,
with the participant walking 400 m ‘as quickly as possible’.
Muscle strength, mass, and quality
Maximum quadriceps muscle strength was defined as the highest of
three consecutive values of torque (Nm) measured by left leg concentric
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knee extensor contraction at an angular velocity of 30° per s using an
isokinetic dynamometer (Biodex Multi-Joint System-PRO with Advantage
Software V.4X, Biodex Medical Systems, Inc., Shirley, NY, USA;
Hartmann et al., 2009). This torque value is equal to the force generated
during the knee extension, multiplied by the length from the knee to the
point where the dynamometer is applied on the tibia. Thigh muscle
cross-sectional area was also measured for the left leg, from 10-mm slice
thickness computed topography (CT) images acquired at midfemur
(Somatom Sensation 10; Siemens, Malvern, PA, USA) and quantified by
customized software with manual checking for quality control (GEANIE
software, version 2.1; BonAnalyse, Jyvaskyla, Finland). Density thresh-
olding was used to separate fat from muscle tissue (at a threshold of
35 mg mm1) and to separate muscle from bone tissue (at a threshold
of 180 mg mm1). In addition, any intramuscular fat that was macro-
scopically detectable was also excluded from the calculation of muscle
area. Muscle quality was defined as the ratio of maximum left quadriceps
peak torque (Nm) to thigh muscle cross-sectional area (cm2) (Moore
et al., 2014).
Oral glucose tolerance test
For the oral glucose tolerance test (OGTT), participants fasted for 10 h
overnight, and fasting plasma was collected at baseline (0 min). Partic-
ipants then drank a 75-g glucose solution and plasma sampleswere drawn
every 20 min for 120 min. Glucose levels were quantified with a glucose
oxidase analyzer (YSI Incorporated, Yellow Springs, OH, USA), and plasma
insulin was assessed by enzyme-linked immunosorbent assay (ELISA)
(Mercodia Inc., Winston-Salem, NC, USA). Complete OGTT data at
baseline and at 2 h were collected during the same visit as the 31P MRS,
gait speed, and maximum quadriceps muscle strength testing for 300
participants. Participants on insulin are excluded from the test.
IL-6 quantification
Blood serum samples were assayed to assess cytokine levels. IL-6
concentrations were quantified using ELISA kits (R&D System, Min-
neapolis, MN, USA), with intra- and interassay variations of 1.6–4.2%
and 0.3–6.4%, respectively. Complete IL-6 data were collected for 293
participants with same-visit data for all other measurements.
31P MRS
The 31P muscle bioenergetics measurement protocol was identical to
that outlined previously (Choi et al., 2016). In vivo spectra of
31P-containing metabolites were acquired using a 3T Philips Achieva
MR scanner (Philips, Best, The Netherlands) and a 10-cm 31P-tuned
surface coil (PulseTeq, Surrey, UK) fastened over the left thigh vastus
lateralis muscle. Participants performed a rapid ballistic knee extension
exercise while lying supine in the bore of the magnet; this maneuver was
practiced before entering the magnet (Coen et al., 2013; Choi et al.,
2016). A series of pulse-acquire 31P spectra were obtained before,
during, and after the knee extension exercise. The pulse sequence
consisted of adiabatic RF excitation pulses with a 90-degree flip angle. A
total of 75 dynamic acquisitions were performed, with TR = 1.5 s, and
the raw data consisted of spectra obtained at 1.5-s temporal resolution.
Signals were averaged over four successive acquisitions for SNR
enhancement, so that the data consisted effectively of spectra obtained
with a temporal resolution of 6 s (i.e., a 6-s interval between consecutive
time points and a total scan duration of 7.5 min). The length of exercise
was monitored to achieve between a 33 and 66% reduction in PCr peak
height and never exceeded 42 s, with a postexercise recovery period of
5.8–6.3 min; spectra were processed using JMRUI (version 5.0) and
quantified using a nonlinear least squares algorithm (AMARES; Van-
hamme, Vanhamme et al., 1999; Naressi et al., 2001).
Skeletal muscle oxidative ATP resynthesis rate determined by
31P MRS
The recovery rate for phosphocreatine was calculated by fitting the
postexercise time-dependent change in PCr to a mono-exponential
function of the form:
PCr(t) ¼ PCr0 þ DPCrð1 exp (- t=sPCrÞÞ ð1Þ
where PCr0 is the end-of-exercise PCr signal area (i.e., the PCr signal area
at the beginning of the recovery period), DPCr is the decrease in signal
area from its pre-exercise baseline value of PCrbaseline to PCr0 resulting
from in-magnet exercise, and sPCr is the PCr exponential recovery time
constant. The inverse of sPCr, kPCr (= 1/sPCr), is thus the recovery rate
constant. This is taken as an index of in vivo muscle oxidative
phosphorylation capacity, as there are minimal other energy demands
during this resting period; postexercise PCr resynthesis is considered
primarily a function of maximum mitochondrial ATP production with no
or minimal contribution of anaerobic metabolism (Arnold et al., 1984;
McCully et al., 1993, 2009; Conley et al., 2000; Edwards et al., 2012).
The % PCr depletion (Walsh et al., 2001; Smith et al., 2004) was
determined by calculation of the decrease in the PCr peak area from pre-
exercise PCrbaseline to PCr0; this use of area is distinct from the use of PCr
peak height in real-time monitoring of bioenergetics status during
exercise. The intramuscular pH was also monitored (calculated according
to the chemical shift of inorganic phosphate, Pi, relative to PCr) to avoid
acidosis and ensure that intramuscular pH did not drop below 6.80
(Arnold et al., 1984).
Statistical analyses
The distributions of population characteristics were compared across
age-adjusted tertiles of muscle strength using analysis of variance, the
Fisher exact test, and the Jonckheere–Terpstra test for trend.
The cross-sectional relationships between age, sex, height (cm),
weight (kg), kPCr (per s), % PCr depletion, and outcomes of muscle area,
muscle strength, and muscle quality were evaluated in linear regression
models; all linear regression coefficients were standardized so as to be
comparable. Possible nonlinearity in the relationships between mito-
chondrial function and muscle area, muscle strength, and muscle quality
was investigated by adding a quadratic term for kPCr to the final models;
this quadratic term was not found to be statistically significant for any of
these outcomes. Similarly, an interaction term between sex and kPCr,
when added to the final models, was also not statistically significant
(P > 0.10). The % PCr depletion term was included as an adjustment to
control for exercise intensity among participants (Walsh et al., 2001;
Smith et al., 2004). In addition, to address the combined use of new
observations (n = 243) with previously published older ones (n = 83,
from Choi et al., 2016), corresponding interaction terms were tested in
all of the final models and were found not to be statistically significant
(P > 0.05). By including an indicator for ‘new data’, and testing its
interaction with kPCr in predicting the outcome of interest, separate
models for each temporal set were essentially fit at once. The lack of
statistically significant interactions indicates the consistency of the two
datasets, as expected, as they were acquired with identical experimental
protocols and analyses.
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To test whether the relationship of kPCr with maximum quadriceps
muscle strength was mediated by a pro-inflammatory state or impaired
glucose metabolism, we tested the partial correlations between kPCr and
baseline glucose, baseline insulin, 2-h glucose after OGTT, and IL-6
levels, individually, after adjusting for age, sex, height, weight, and PCr
depletion. None of these were found to be statistically significant, and
including these same variables in multivariate linear regression models
predicting maximum muscle quadriceps strength did not markedly
attenuate the magnitude or significance of the effect of kPCr.
To evaluate the relationship between muscle strength, kPCr, and
the four different walking speed outcomes, we fit a set of linear
regression models for each walking task, adjusting for sex, height,
weight, and % PCr depletion in every model. For each walking task
(Table 3), Model 1 demonstrates the effect of muscle strength on
walking speed. Model 2 estimates the coefficient linking kPCr and
walking speed, and Model 3 adds muscle strength to Model 2 to
evaluate changes in the size of the coefficient linking kPCr to walking
speed after adjusting for muscle strength. The Sobel test was
performed to evaluate whether muscle strength mediates the effect
of kPCr on walking speed for all four walking tasks. We also
computed the proportion of the association between kPCr and walking
speed that is explained by muscle strength. In addition, kPCr
2 and sex–
kPCr interaction terms were tested and as they did not contribute
significantly to the models’ fit, these terms were removed from the
models. All analyses were performed using R version 3.3.1 (R
Foundation for Statistical Computing, Vienna, Austria), and P < 0.05
was considered statistically significant for all analyses.
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